These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 7243757)

  • 21. Comparative study of biweekly streptomycin and isoniazid with daily P.A.S. and isoniazid regimens in the treatment of pulmonary tuberculosis.
    Mathur JB; Bahadur P; Agnihotri CB
    J Indian Med Assoc; 1967 Aug; 49(4):162-5. PubMed ID: 5594009
    [No Abstract]   [Full Text] [Related]  

  • 22. [Patterns of the healing processes of the tuberculotic lung cavern].
    Novoselova VP
    Probl Tuberk; 1980 Feb; (2):52-6. PubMed ID: 7375464
    [No Abstract]   [Full Text] [Related]  

  • 23. [Results of polychemotherapy in patients with newly detected destructive pulmonary tuberculosis].
    Berezovskiĭ BA; Popova II; Pshevorskiĭ VIa
    Probl Tuberk; 1990; (4):50-2. PubMed ID: 2118644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Has the intermittent therapy of pulmonary tuberculosis a future in industrialised countries?].
    Gyselen A; Verbist L
    Prax Pneumol; 1972 May; 26(5):269-82. PubMed ID: 5047988
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of lymphotropic therapy in the multimodality treatment of patients with pulmonary tuberculosis and comorbidity].
    Ubaĭdullaev AM; Belotserkovets VG
    Probl Tuberk Bolezn Legk; 2004; (12):50-2. PubMed ID: 15719669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M; Bek E
    Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
    [No Abstract]   [Full Text] [Related]  

  • 27. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR; Agarwal SK; Shah KV
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Basis for the administration of streptomycin and isoniazid in ultrasonic aerosols in the treatment of intrathoracic tuberculosis].
    Semenova EV
    Antibiotiki; 1977 May; 22(5):469-71. PubMed ID: 879731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of short-course, intermittent chemotherapy for tuberculosis in young infants aged less than 6 months.
    Kiper N; Göçmen A; Dilber E; Ozçelik U
    Clin Pediatr (Phila); 1998 Jul; 37(7):433-6. PubMed ID: 9675437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Blood coagulation state in destructive pulmonary tuberculosis patients under different methods of chemotherapy].
    Sagalovich VIa; Beresneva RE; Ivanova VB
    Probl Tuberk; 1981 May; (5):30-4. PubMed ID: 7255385
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effectiveness of various chemotherapy programs in patients with disseminated destructive pulmonary tuberculosis].
    Novikova TM
    Probl Tuberk; 1985; (2):66-7. PubMed ID: 4001099
    [No Abstract]   [Full Text] [Related]  

  • 33. [A case of polymyositis complicated with pulmonary tuberculosis concerned with steroid resistance due to rifampin administration].
    Shinoda C; Hayashi R; Kawasaki A; Maruyama M; Kobayashi M
    Nihon Kokyuki Gakkai Zasshi; 2001 Dec; 39(12):955-60. PubMed ID: 11875815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chemotherapy with isoniazid and rifampicin for pulmonary tuberculosis].
    Kawakami K
    Kekkaku; 2002 Aug; 77(8):569-71. PubMed ID: 12235849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liposome-based antitubercular drug therapy in a guinea pig model of tuberculosis.
    Pandey R; Sharma S; Khuller GK
    Int J Antimicrob Agents; 2004 Apr; 23(4):414-5. PubMed ID: 15081096
    [No Abstract]   [Full Text] [Related]  

  • 36. [Duration of the treatment of tuberculosis in 1981].
    Sors C; Dautzenberg B; Grosset J
    Nouv Presse Med; 1982 Mar; 11(11):831. PubMed ID: 7070974
    [No Abstract]   [Full Text] [Related]  

  • 37. [Intermittent long-term cheomotherapy in experimental tuberculosis of the mouse].
    Grumbach F
    Bull Int Union Tuberc; 1968 Dec; 41():303-8. PubMed ID: 5710255
    [No Abstract]   [Full Text] [Related]  

  • 38. [Results of planned treatment of tuberculosis, under field conditions, with a therapeutic regimen consisting of isoniazid, rifampicin and streptomycin].
    González Montaner LJ; Palma Beltrán O; Abbate E; Dambrosi A; Mosca C
    Bull Int Union Tuberc; 1983 Jun; 58(2):108-10. PubMed ID: 6360262
    [No Abstract]   [Full Text] [Related]  

  • 39. [An experimental study of the chemotherapeutic efficacy of flurenizid, a new antitubercular pharmaceutical].
    Khomenko AG; Golyshevskaia VI; Maslova LI; Kalmykova GN; Uvarova OA
    Probl Tuberk; 1990; (6):3-7. PubMed ID: 2217100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Bactericidal therapy in patients with tuberculosis].
    Krasnov VA; Ursov IG
    Probl Tuberk Bolezn Legk; 2004; (3):21-6. PubMed ID: 15338895
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.